Description: The focus of the webcast on Modeling Long–Term Medical Trends for Valuation Purposes was a discussion of the underlying methodology of the model, a walk through of the actual model, and a review of the considerations for its practical usage by actuaries. The running time of this video is 1 hour and 3 minutes. It is a presentation of slides without audio.

Description: This session covers current topics of interest to self-funded health benefit programs. Topics include carve-out of pharmacy, participation in employer coalitions for pooling of risk and negotiating favorable terms with providers and administrators, stop loss insurance market developments and transparency. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 51

Description: A panel of practicing actuaries and policy analysts will discuss the 'big issues' that could affect the actuarial profession in the future, and suggest ideas on how the actuarial profession could adapt to these challenges. This will be an interactive session where attendees can expect to have an opportunity to weigh in through polling questions and discussion. Topics touched will include: socialized medicine, artificial intelligence, the competition from data scientists, data commoditization, disruption from new entrants into the healthcare insurance space, and more.

Description: This session will describe best practices for the preparation of the actuarial memorandum that supports the statement of actuarial opinion that is part of a health annual statement and review highlights of the new (2019) practice note on this topic. Presenters will represent different perspectives to discuss the components of an actuarial memorandum and use examples to present best practices and practical application of the information presented in the practice note.

Description: Predictive Analytics and Epigenetics are two of the most impactful driving forces for the future of healthcare, precision medicine, and insurance. Learn why this is true, how if will change the way our industry operates, and how you can stay viable and contribute to the betterment of humanity while also protecting the actuarial profession from obsolescence. Learn how personalized medicine keying off genetic testing is saving life insurers big dollars. The only limit seems to be testing access for their insureds.

Description: This session discussion is about state-mandated health benefits. Who should decide and who should pay? The basis of making decisions, effect on insurance rates, impact on self-insurance, legislative process and timing of savings. From Record of Society of Actuaries Vol. 16, No. 1.

Description: This session is about structuring an HMO, rating, financing & solvency and underwriting. From Record of Society of Actuaries 1979 Vol. 5, No. 4.

Description: This session discussion is about Aids and pricing, underwriting, contract limits, claim reserves, current experience, modeling, and future outlook. From Record of the Society of Actuaries 1988 Vol. 14, No. 1.

Description: This session discussion is about AIDS: Experience, trends and projections, medical and disability points of view, pricing, underwriting and epidemiologic implications and results of survey on current practices. From Record of Society of Actuaries Vol. 18, No. 1B.

Description: This session discussion is about development of medical cost estimates, differences between indemnity and HMO techniques, relationship of premiums and capitations, HMO organizational structures, experience rating, community rating and community rating by class. From Record of the Society of Actuaries 1987 Vol. 13, No. 1.